News

Comic Vision Tickets On Sale Now!

Comic Vision Tickets On Sale Now!

February 6th, 2018 by FFB Canada

We are thrilled to announce that Comic Vision is back for another hilarious year of sight-saving comedy. Since 1999, Comic Vision has spread hope and humour coast-to-coast and raised a game-changing $9 million for sight-saving research, treatments and cures for blindness. TICKETS ON SALE NOW! On Thursday, April 19th, Comic Vision Toronto kicks off this year’s tour…

Read More

Four Vision Research and Treatment Trends to Watch in 2018   

Four Vision Research and Treatment Trends to Watch in 2018   

January 22nd, 2018 by FFB Canada

With the December 2017 announcement that the world’s first ocular gene therapy had received approval by the U. S. Food and Drug Administration (FDA), there’s no doubt that 2017 was a landmark year for gene therapy. Looking back, 2017 was a year of firsts, including the first stem cell therapy clinical trial for macular degeneration…

Read More

Shorcan Charity Day Raises $7,000 for Vision Research

Shorcan Charity Day Raises $7,000 for Vision Research

January 19th, 2018 by FFB Canada

Yesterday, we helped TMX Group close the market for the 20th Shorcan Charity Day! For the last 20 years, Shorcan Brokers Limited has donated one day’s profits to charities, including the Foundation Fighting Blindness (FFB). Today, we’re thrilled to announce that the FFB and the crucial vision research we support will benefit from $7,000 thanks to…

Read More

Racing Against the Clock

Racing Against the Clock

January 18th, 2018 by FFB Canada

Unless there is a research breakthrough very soon, Shelagh Anson’s children will lose their sight in their teens. Rowan and Caroline were born with Usher Syndrome, a disease that affects hearing and sight. They’ve both had hearing problems from day one, but cochlear implants have helped with that. They also have difficulties with balance, but…

Read More

2018 National Young Leaders Summit: Register Now!

2018 National Young Leaders Summit: Register Now!

December 28th, 2017 by Dr. Chad Andrews

The Foundation Fighting Blindness is thrilled to announce details for this year’s National Young Leaders Summit. The event will take place in Toronto on the evening of Friday, March 9 and during the day on Saturday, March 10, 2018. We are partnering with the Canadian National Institute for the Blind to hold the Summit at their Community Hub at…

Read More

2017 in Review: The Most-Read FFB Stories of 2017

2017 in Review: The Most-Read FFB Stories of 2017

December 22nd, 2017 by FFB Canada

At the FFB, we love writing about vision research. In 2017, we wrote more than 50 stories to share news about stem cell discoveries, CRISPR gene-editing, promising new drug therapies, and emerging treatments for blinding eye disease. Have you read them all? The best place to start is with our top 10 most-read stories of…

Read More

First gene therapy for a blinding eye disease receives FDA approval

First gene therapy for a blinding eye disease receives FDA approval

December 19th, 2017 by Dr. Mary Sunderland

Today we are celebrating the FDA’s pathbreaking approval of Luxturna. We have been following the development of Luxturna closely. Today’s landmark FDA approval makes Luxturna the first gene therapy approved in the US that targets a disease caused by mutations in a specific gene. The next steps involve determining the price for Luxturna, which poses…

Read More

Survival of the Fittest: Sustaining Cells Through Transplantation

Survival of the Fittest: Sustaining Cells Through Transplantation

December 18th, 2017 by Dr. Chad Andrews

In many retinal diseases, vision loss occurs when cells that are crucial for vision are damaged or lost. This is the case, for example, in age-related macular degeneration (AMD), retinitis pigmentosa, choroideremia, and Stargardt disease. To reverse vision loss resulting from these and similar diseases, we need to develop and refine our ability to replace…

Read More

Understanding the Retina: AMD and Exploratory Science

Understanding the Retina: AMD and Exploratory Science

December 1st, 2017 by Dr. Chad Andrews

In medicine, innovative treatments don’t emerge out of thin air; they are the result of a series of advancements in our understanding of how genes, molecules, and cells interact. The human eye is no stranger to this rule. In fact, there is still much we don’t understand about the genetic and cellular foundations of sight….

Read More